Cargando…

MON-029 Polycystic Ovary Syndrome (PCOS) in Adolescent Girls:Toward a Simple On-Treatment Predictor of Post-Treatment Ovulation Rate

There is no approved treatment for adolescent girls with PCOS. The vast majority of these patients are guided into a trajectory that starts with oral contraceptive (OC) treatment, leads into oligo-anovulatory subfertility, then into the use of assisted reproductive techniques, and ultimately into pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibanez, Lourdes, Díaz, Marta, Cereijo, Ruben, Bassols, Judit, Lopez-Bermejo, Abel, Villarroya, Francesc, de Zegher, Francis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209001/ http://dx.doi.org/10.1210/jendso/bvaa046.320

Ejemplares similares

FRI426 Raised Thyroid Stimulating Hormone In Girls With Polycystic Ovary SyndromeEffects Of Randomized Interventions
por: Ibanez, Lourdes, et al.
Publicado: (2023)

The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat
por: de Zegher, Francis, et al.
Publicado: (2021)

Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome
por: Ibáñez, Lourdes, et al.
Publicado: (2020)

Author Correction: The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat
por: de Zegher, Francis, et al.
Publicado: (2021)

Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization
por: García-Beltran, Cristina, et al.
Publicado: (2020)

MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model
por: Rodriguez Paris, Valentina, et al.
Publicado: (2019)

ODP426 SPIOMET4HEALTH: a 4-Arm Trial to Test the Effects of Lifestyle Intervention plus either Placebo, or Pioglitazone (PIO), or Spironolactone-Pioglitazone (SPIO), or Spironolactone-Pioglitazone-Metformin (SPIOMET) in Adolescent Girls and Young Women with PCOS
por: Ibanez, Lourdes, et al.
Publicado: (2022)

OR25-3 Toward a Circulating Marker of Hepato-Visceral Fat Excess: S100A4 in Adolescent Girls with Polycystic Ovary Syndrome
por: Ibanez, Lourdes, et al.
Publicado: (2019)

Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome
por: Díaz, Marta, et al.
Publicado: (2018)

MON-234 Targeted Profiling of Plasma MicroRNAs in Women with Polycystic Ovary Syndrome (PCOS): Impact of Obesity
por: Almawi, Wassim, et al.
Publicado: (2019)

MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature
por: Shirin, Sonia, et al.
Publicado: (2020)

MON-213 Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Factors in Reproductive-Age Women with Polycystic Ovary Syndrome (PCOS) Using the 2014 Androgen Excess and PCOS Society Criteria for the Polycystic Ovarian Morphology
por: Kazemi, Maryam, et al.
Publicado: (2019)

MON-LB9 Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS) - Person-Related 6-Month Experience Changes
por: Shirin, Sonia, et al.
Publicado: (2020)

MON-022 Dissecting the Interplay Between Diet and PCOS Pathology on Gut Microbiota in a PCOS Mouse Model
por: Paris, Valentina Rodriguez, et al.
Publicado: (2020)

MON-043 Sleep Disturbances in Women with and Without Polycystic Ovary Syndrome (PCOS) and Their Association with Lifestyle Factors (Diet, Physical Activity and Sitting Time)
por: Bennett, Christie, et al.
Publicado: (2020)

SAT-222 Hormone Responses Associated with Letrozole Ovulation Induction in Anovulatory Women with PCOS
por: Hadnott, Tracy, et al.
Publicado: (2019)

MON-230 Androgen-Induced Disruption of the Biological Clock: The Link between PCOS and NAFLD
por: Abudu, Aierken, et al.
Publicado: (2019)

MON-LB001 Ovulation Induction Results in Altered Growth and Metabolic Dysfunction in Mice Offspring
por: Harner, Royce, et al.
Publicado: (2020)

Bone Morphogenetic Protein-8B Levels at Birth and in the First Year of Life: Relation to Metabolic-Endocrine Variables and Brown Adipose Tissue Activity
por: Garcia-Beltran, Cristina, et al.
Publicado: (2022)

SUN-029 Diabetes Mellitus Associated with Klinefelter Syndrome
por: Sarria, Carolina, et al.
Publicado: (2020)

MON-208 Association Study of AMH Promoter Polymorphisms and Serum AMH Levels in PCOS Patients
por: Moolhuijsen, Loes, et al.
Publicado: (2019)

MON-204 Gut Bacterial Composition Correlates with an Improved PCOS Phenotype after Co-Housing
por: Thackray, Varykina, et al.
Publicado: (2019)

MON-034 Impact of Race and Obstructive Sleep Apnea on Glucose and Insulin Regulation in Women with PCOS
por: Temple, Karla A, et al.
Publicado: (2020)

MON-LB043 Bariatric Surgery and Weight Loss: Effect on Glucose/Insulin Dynamics in Adolescent PCOS
por: Fennoy, Ilene, et al.
Publicado: (2019)

MON-035 Does Androgen Exposure Result in Germline Transmission of PCOS-Like Phenotypes and Can It Be Reversed?
por: Lu, Haojiang, et al.
Publicado: (2020)

SAT-029 AMH Is Higher Across the Menstrual Cycle in Early Post-Menarchal Girls Than in Ovulatory Women
por: Ortega, Madison T, et al.
Publicado: (2020)

OR33-1 Metabolic Inflexibility in Obese versus Lean Women with Polycystic Ovary Syndrome (PCOS): Is PCOS Status or Adiposity the Critical Factor?
por: Gebara, Nour, et al.
Publicado: (2019)

MON-205 Is Muscle Mechanical Function Altered In Polycystic Ovary Syndrome?
por: Caliskan Guzelce, Ezgi, et al.
Publicado: (2019)

MON-216 Sexual Dysfunction and Eating and Sleeping Disorders in Women with PCOS: A Systematic Review and Meta-Analysis
por: Alsawas, Mouaz, et al.
Publicado: (2019)

SAT353 Relevance of Ovarian Morphology Among Adolescents With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

PMON245 Clinical Phenotypes of Polycystic Ovary Syndrome (PCOS) in Nigerian Women: Preliminary Results of the Nigeria PCOS Epidemiology & Phenotype (Nigeria-Pep) Study
por: Balogun, Mobolanle, et al.
Publicado: (2022)

SAT365 Prevalence of Polycystic Ovary Syndrome (PCOS) in Health System and Insurer Records vs. the Prevalence in the Population: Evidence for the Significant Underdiagnosis and Undertreatment of PCOS
por: Hatoum, Sana, et al.
Publicado: (2023)

MON-220 Androstendione Affects Endometrial Gene Expression Profile During Window of Implantation in Obese Infertile Women with PCOS
por: Jensterle Sever, Mojca, et al.
Publicado: (2019)

MON-033 Androgen Increases the Accumulation of Advanced Glycation End Products in Granulosa Cells by Activating ER Stress in PCOS
por: Azhary, Jerilee Mariam Khong, et al.
Publicado: (2020)

MON-040 11-Oxygenated C19 Steroids in Polycystic Ovarian Syndrome
por: Mody, Armaiti, et al.
Publicado: (2020)

MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome
por: Jarrett, Brittany, et al.
Publicado: (2019)

SUN-012 Role of Leptin-Receptor Expressing Cells in the Pathogenesis of Polycystic Ovary Syndrome (PCOS)
por: Cara, Alexandra, et al.
Publicado: (2020)

SAT388 Does Obesity Drive the Development of Polycystic Ovary Syndrome (PCOS)? An Epidemiologic Study
por: Amiri, Mina, et al.
Publicado: (2023)

Assessment of Depression Among Adolescent Indian Girls With PCOS
por: Talwar, Vipan, et al.
Publicado: (2021)

MON-201 ER Stress Activated by Androgen Enhances Apoptosis of Granulosa Cells via Induction of Death Receptor 5 in PCOS
por: Azhary, Jerilee, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f97uufe0190g55aaal3sqpp9sv